“Much of the Scientific Literature, Perhaps HALF, May Simply Be Untrue”
Filed under: Book Reviews | Tagged: JAMA, JAPMA, JBBS, Lancet, medical journals, New England Journal of Medicine | Leave a comment »
Filed under: Book Reviews | Tagged: JAMA, JAPMA, JBBS, Lancet, medical journals, New England Journal of Medicine | Leave a comment »
When is a “Journal” … not a Journal?
By Dr. David Edward Marcinko; MBA, CMP™
Allow me to begin this post by making the unusual disclosure that I was the Editor-in-Chief of a print guide in healthcare finance and economics [aka periodical or journal].
Formally, the title was: Healthcare Organizations [Financial Management Strategies]. At 2 volumes, and more than 1,200 pages, it was quite a job to update it quarterly. And, with more than two dozen contributing authors, it was a labor of love indeed. Alas … no more!
Varying Levels of Credibility
Now, we doctors know that medical journals are not all alike. There are different levels of “credibility.” Some are peer-reviewed, others not. Some are trade magazines. Frankly, some “real” journals are better, and more respected than others. Some entrenched journals are in decline, while other emerging journals are leading-edge in the health 2.0 space. Still others, like the formerly esteemed Journal of the American Medical Association [JAMA], have been accused of outright censorship.
Link: https://healthcarefinancials.wordpress.com/2009/04/02/is-jama-censoring-physician-dissent/
Adventures
Of course, doctors also know that pharmaceutical companies routinely offer us reprints of articles from medical journals that are favorable to their products. But, news of a Merck-sponsored publication for doctors in Australia has come to light in a personal injury lawsuit over Vioxx. It raised more than a few eyebrows in international medical publishing circles. It may have even crossed the line of journalistic, not to mention medical, ethics.
Read: Merck Paid for Medical ‘Journal’ Without Disclosure; by Natasha Singer, May 13, 2009.
Mis-Adverntures
Tracy Staton wrote more about these mis-adventures in a story, dated May 14, 2009, in FiercePharma.
Analysis and Apology
Analysis in the Pipeline: http://seekingalpha.com/article/136942-merck-and-elsevier-cross-the-line-in-joint-medical-journal?source=yahoo
Libology Mea Culpa: http://www.libology.com/blog/tag/excerpta-medica
Assessment
Perhaps; Merck ought to read our Medical-Executive Post on health journalists?
Link: https://healthcarefinancials.wordpress.com/2009/03/17/battered-health-journalists
Or, our Medical-Executive Post on medical experts, reporters and journalists?
Link: https://healthcarefinancials.wordpress.com/2009/03/09/healthcare-experts-versus-health-journalists
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: "Doctors Only", Breaking News, Career Development, Drugs and Pharma, Ethics, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., Op-Editorials, Recommended Books, Risk Management | Tagged: big-pharma, david marcinko, Drugs, JAMA, medical journals, Merck, Natasha Singer, pharmaceticals, Tracy Staton, Vioxx, www.healthcarefinancials.com | 12 Comments »
Our Print Mission Statement
[By Dr. David Edward Marcinko; MBA, CMP™]
Publisher-in-Chief
As Editor-in-Chief of a two volume – 1,200 pages – premium quarterly print journal, I am often asked about our mission statement; or the journal’s raison d’etra.
A Two-Volume Guide
As so, Healthcare Organizations: [Financial Management Strategies], with its quarterly updates, will promote and integrate academic and applied research, and serve as a multi-disciplined communications forum for the dissemination of financial, managerial, business and related economic information to decision makers in hospitals, outpatient centers, clinics, medical practices and all mature and emerging healthcare organizations.
Target Market and Ideal Reader
Healthcare Organizations [Financial Management Strategies] and its quarterly updates should be in the hands of all:
* CFOs, CEOs, COOs, CTOs, VPs and CIOs from every type of hospital and healthcare organization including: public, federal, state, Veteran’s Administration and Indian Health Services hospitals; district, rural, long-term care and community hospitals; specialty, children’s and rehabilitation hospitals; diagnostic imaging centers and laboratories; private, religious-sponsored, and psychiatric institutions.
* Physician Hospital Organizations, Management Services Organizations (MSOs), Independent Practice Associations (IPAs), Group Practices Without Walls (GPWWs), Integrated Delivery Systems (IDSs) and their administrators, comptrollers, cost accountants, budget directors, cash managers, auditors, healthcare attorneys and consultants, and actuaries, and all endowment fund directors, executives, consultants and strategic financial managers.
* Ambulatory care centers, hospices, and outpatient clinics; skilled nursing facilities, integrated networks and group practices; academic medical centers, nurses and physician executives; business school and health administration students, and all economic decision-makers and directors of allopathic, dental, podiatric and osteopathic healthcare organizations.
Assessment
After publication, my suggestion is to read, study and act upon the guide in this way:
1. First, browse through the entire text.
2. Next, slowly read those chapters and sections that are of specific interest to your professional efforts.
3. Then, extrapolate portions that can be implemented in specific strategies helpful to your healthcare setting.
4. Finally, use its’ ME-P updates as a reference manual to return to time and time again; and enjoy!
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Filed under: Accounting, Book Reviews, Career Development, Drugs and Pharma, Ethics, Experts Invited, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., Information Technology, Managed Care, Practice Management, Practice Worth, Professional Liability, Recommended Books, Research & Development, Risk Management, Sponsors | Tagged: administrators, ASCs, CEO, CFO, children’s hospitals, clinics, community hospitals, COO, CXO, david marcinko, diagnostic imaging centers, DO, doctors, DPM, healthcare administration, Healthcare Organizations, hospital management, hospitals, Indian Health Services, laboratories, long term care, MD, medical journals, medical practice management, medical practices, nurse executives, nurses, oasteopaths, OD, office managers, outpatient centers, physicians, physisician executives, podiatrists, practice managers, psychiatric institutions, rehabilitation hospitals, RNs, rural hospitals, specialty hospitals, Veterans Administration | 1 Comment »